DUPIXENT (dupilumab) injection. FDA Approved

DUPIXENT (dupilumab) injection can be ordered by patient or doctor, if the drug has not been approved or is not available in your country. Medvitaz Pharma Solutions can help you from India to get best price/cost of DUPIXENT (dupilumab) injection to treat the symptoms of eczema (atopic dermatitis; a skin disease.
Category: .

DUPIXENT (dupilumab) injection, for subcutaneous use. Initial U.S. Approval: 2017

DUPIXENT (dupilumab) injection is a prescription medicine. DUPIXENT (dupilumab) injection is used to treat people aged 6 years and older with moderate-to-severe atopic dermatitis (eczema).
INDICATIONS AND USAGE
DUPIXENT is an interleukin-4 receptor alpha antagonist indicated for the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.
DOSAGE FORMS & STRENGTHS
• Injection: 300 mg/2 mL solution in a single-dose pre-filled syringe with needle shield
• Injection: 300 mg/2 mL solution in a single-dose pre-filled syringe
Manufactured By: Regeneron
Prescribing Information URL: Click Here

Access to DUPIXENT (dupilumab) injection Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis.

Dupilumab appears to be useful for moderate-to-severe atopic dermatitis for which it is approved in the United States. It is also being evaluated for treatment of persistent asthma in adults and adolescents. In October 2019, the European Commission (EC) approved Dupixent in chronic rhinosinusitis with nasal polyposis (CRSwNP).

In September 2020, the FDA granted dupilumab breakthrough therapy status for the treatment of eosinophilic esophagitis.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.